Why choose Insightec?

INSIGHTEC is transforming patient lives through incisionless surgery. Our proprietary MR-guided Focused Ultrasound technology is based on over two decades of scientific expertise and clinical research. The company's award-winning Exablate® Neuro platform delivers sound waves precisely targeted to treat deep in the brain with no incisions.

Who owns Insightec?

Insightec is controlled by Canada’s Koch Disruptive Technologies (KDT. That firm currently holds a 40% stake in the company, having invested $200 million in it. Will you offer us a hand? Every gift, regardless of size, fuels our future.

Is InSightec ready for an SPAC merger?

Insightec, an Israeli global healthcare medtech company that offers a device for minimally invasive surgery based on ultrasound, is ready for an SPAC merger ahead of its initial public offering IPO. Globes has reported that sources at the company revealed that Insightec expects to end up with a $2 billion valuation, once the deal is completed.